Analysis of clonal type-specific antibody reactions in toxoplasma gondii seropositive humans from germany by peptide-microarray

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Maksimov, Pavlo ^a   Zerweck, Johannes ^b   Maksimov, Aline ^a   Hotop, Andrea ^c   Groß, Uwe ^c   Spekker, Katrin ^d   Däubener, Walter ^d   Werdermann, Sandra ^e   Niederstrasser, Olaf ^f   Petri, Eckhardt ^g   Mertens, Marc ^a   Ulrich, Rainer G ^a   Conraths, Franz J ^a   Schares, Gereon ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b JPT Peptide Technologies GmbH   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e Institut für Arbeits und Sozialhygiene Stiftung   (Germany)

^f BG KLINIKEN BERGMANNSTROST   (Germany)

^g GSK Marburg Vaccines and Diagnostics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PROTOZOON ANTIBODY; PARASITE ANTIGEN; PEPTIDE;

ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; FOREST WORKER; GERMANY; HUMAN; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; PROTEIN MICROARRAY; SENSITIVITY AND SPECIFICITY; SEROTYPING; TOXOPLASMA GONDII; TOXOPLASMOSIS; BLOOD; IMMUNOLOGY; SYNTHESIS; TOXOPLASMA;

TOXOPLASMA GONDII;

ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; GERMANY; HUMANS; PEPTIDES; PROTEIN ARRAY ANALYSIS; SEROTYPING; TOXOPLASMA; TOXOPLASMOSIS;

EID: 84859093878     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034212     Document Type: Article

References (56)

1. Janitschke K, Held T, Kruiger D, Schwerdtfeger R, Schlier G, et al. (2003) Diagnostic value of tests for Toxoplasma gondii-specific antibodies in patients undergoing bone marrow transplantation. Clin Lab 49: 239-242.
2. Montoya JG, Liesenfeld O, (2004) Toxoplasmosis. Lancet 363: 1965-1976.
3. Jones JL, Lopez A, Wilson M, Schulkin J, Gibbs R, (2001) Congenital toxoplasmosis: a review. Obstet Gynecol Surv 56: 296-305.
4. Howe DK, Sibley LD, (1995) Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis 172: 1561-1566.
5. Howe DK, Honor' S, Derouin F, Sibley LD, (1997) Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis. J Clin Microbiol 35: 1411-1414.
6. Ajzenberg D, Banuls AL, Tibayrenc M, Darde ML, (2002) Microsatellite analysis of Toxoplasma gondii shows considerable polymorphism structured into two main clonal groups. Int J Parasitol 32: 27-38.
7. Sibley LD, Khan A, Ajioka JW, Rosenthal BM, (2009) Genetic diversity of Toxoplasma gondii in animals and humans. Philos Trans R Soc Lond B Biol Sci 364: 2749-2761.
8. Khan A, Dubey JP, Su C, Ajioka JW, Rosenthal BM, et al. (2011) Genetic analyses of atypical Toxoplasma gondii strains reveal a fourth clonal lineage in North America. Int J Parasitol 41: 645-55.
9. Dubey JP, Graham DH, Dahl E, Sreekumar C, Lehmann T, et al. (2003) Toxoplasma gondii isolates from free-ranging chickens from the United States. J Parasitol 89: 1060-1062.
10. Khan A, Su C, German M, Storch GA, Clifford DB, et al. (2005) Genotyping of Toxoplasma gondii strains from immunocompromised patients reveals high prevalence of type I strains. J Clin Microbiol 43: 5881-5887.
11. Ajzenberg D, Yera H, Marty P, Paris L, Dalle F, et al. (2009) Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings. J Infect Dis 199: 1155-67.
12. Carme B, Demar M, Ajzenberg D, Darde ML, (2009) Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana. Emerg Infect Dis 15: 656-658.
13. Grigg ME, Ganatra J, Boothroyd JC, Margolis TP, (2001) Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis 184: 633-639.
14. Sibley LD, Boothroyd JC, (1992) Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 359: 82-85.
15. Su C, Howe DK, Dubey JP, Ajioka JW, Sibley LD, (2002) Identification of quantitative trait loci controlling acute virulence in Toxoplasma gondii. Proc Natl Acad Sci U S A 99: 10753-10758.
16. Boothroyd JC, Grigg ME, (2002) Population biology of Toxoplasma gondii and its relevance to human infection: do different strains cause different disease? Curr Opin Microbiol 5: 438-442.
17. Suzuki Y, (2002) Host resistance in the brain against Toxoplasma gondii. J Infect Dis 185 (Suppl 1): S58-S65.
18. Suzuki Y, (1999) Genes, cells and cytokines in resistance against development of toxoplasmic encephalitis. Immunobiology 201: 255-271.
19. Holland GN, (2004) Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. Am J Ophthalmol 137: 1-17.
20. Saeij JP, Boyle JP, Boothroyd JC, (2005) Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host. Trends Parasitol 21: 476-481.
21. Jamieson SE, Cordell H, Petersen E, McLeod R, Gilbert RE, et al. (2009) Host genetic and epigenetic factors in toxoplasmosis. Mem Inst Oswaldo Cruz 104: 162-169.
22. Kong JT, Grigg ME, Uyetake L, Parmley S, Boothroyd JC, (2003) Serotyping of Toxoplasma gondii infections in humans using synthetic peptides. J Infect Dis 187: 1484-1495.
23. Peyron F, Lobry JR, Musset K, Ferrandiz J, Gomez-Marin JE, et al. (2006) Serotyping of Toxoplasma gondii in chronically infected pregnant women: predominance of type II in Europe and types I and III in Colombia (South America). Microbes Infect 8: 2333-2340.
24. Sousa S, Ajzenberg D, Marle M, Aubert D, Villena I, et al. (2009) Selection of polymorphic peptides from GRA6 and GRA7 sequences of Toxoplasma gondii strains to be used in serotyping. Clin Vaccine Immunol 16: 1158-1169.
25. Sousa S, Canada N, Correia da Costa JM, Darde ML, (2010) Serotyping of naturally Toxoplasma gondii infected meat-producing animals. Vet Parasitol 169: 24-28.
26. Morisset S, Peyron F, Lobry JR, Garweg J, Ferrandiz J, et al. (2008) Serotyping of Toxoplasma gondii: striking homogeneous pattern between symptomatic and asymptomatic infections within Europe and South America. Microbes Infect 10: 742-747.
27. Parmley SF, Gross U, Sucharczuk A, Windeck T, Sgarlato GD, et al. (1994) 2 Alleles of the Gene Encoding Surface-Antigen P22 in 25 Strains of Toxoplasma gondii. J Parasitol 80: 293-301.
28. Grigg ME, Suzuki Y, (2003) Sexual recombination and clonal evolution of virulence in Toxoplasma. Microbes Infect 5: 685-690.
29. Mertens M, Hofmann J, Petraityte-Burneikiene R, Ziller M, Sasnauskas K, et al. (2011) Seroprevalence study in forestry workers of a non-endemic region in eastern Germany reveals infections by Tula and Dobrava-Belgrade hantaviruses. Med Microbiol Immunol 200: 263-8.
30. Hosseininejad M, Azizi HR, Hosseini F, Schares G, (2009) Development of an indirect ELISA test using a purified tachyzoite surface antigen SAG1 for sero-diagnosis of canine Toxoplasma gondii infection. Vet Parasitol 164: 315-319.
31. Wenschuh H, Volkmer-Engert R, Schmidt M, Schulz M, Schneider-Mergener J, et al. (2000) Coherent membrane supports for parallel microsynthesis and screening of bioactive peptides. Biopolymers 55: 188-206.
32. Frank R, Overwin H, (1996) SPOT synthesis. Epitope analysis with arrays of synthetic peptides prepared on cellulose membranes. Methods Mol Biol 66: 149-169.
33. Panse S, Dong L, Burian A, Carus R, Schutkowski M, et al. (2004) Profiling of generic anti-phosphopeptide antibodies and kinases with peptide microarrays using radioactive and fluorescence-based assays. Mol Divers 8: 291-9.
34. Andresen H, Grötzinger C, (2009) Deciphering the antibodyome- peptide arrays for serum antibody biomarker diagnostics. Curr Proteomics 6: 1-12.
35. Ngo Y, Advani R, Valentini D, Gaseitsiwe S, Mahdavifar S, et al. (2009) Identification and testing of control peptides for antigen microarrays. J Immunol Methods 343: 68-78.
36. Nahtman T, Jernberg A, Mahdavifar S, Zerweck J, Schutkowski M, et al. (2007) Validation of peptide epitope microarray experiments and extraction of quality data. J Immunol Methods 328: 1-13.
37. Vigil A, Ortega R, Jain A, Nakajima-Sasaki R, Tan X, et al. (2010) Identification of the feline humoral immune response to Bartonella henselae infection by protein microarray. PloS one 5: e11447.
38. Pamelard F, Even G, Apostol C, Preda C, Dhaenens C, et al. (2009) PASE: a web-based platform for peptide/protein microarray experiments. Methods Mol Biol 570: 413-430.
39. Dominguez-Almendros S, Benitez-Parejo N, Gonzalez-Ramirez AR, (2011) Logistic Regression Models. Allergol Immunopathol (Madr.) 39: 295-305.
40. Bland JM, Altman DG, (1995) Multiple significance tests: the Bonferroni method. B M J 310: 170.
41. Friendly M, (1994) Mosaic Displays for Multiway Contingency-Tables. J A S A 89: 190-200.
42. Nowakowska D, Colon I, Remington JS, Grigg M, Golab E, et al. (2006) Genotyping of Toxoplasma gondii by multiplex PCR and peptide-based serological testing of samples from infants in Poland diagnosed with congenital toxoplasmosis. J Clin Microbiol 44: 1382-1389.
43. Sousa S, Ajzenberg D, Vilanova M, Costa J, Darde ML, (2008) Use of GRA6-derived synthetic polymorphic peptides in an immunoenzymatic assay to serotype Toxoplasma gondii in human serum samples collected from three continents. Clin Vaccine Immunol 15: 1380-1386.
44. Xiao J, Buka SL, Cannon TD, Suzuki Y, Viscidi RP, et al. (2009) Serological pattern consistent with infection with type I Toxoplasma gondii in mothers and risk of psychosis among adult offspring. Microbes Infect 11: 1011-1018.
45. Melnyk O, Duburcq X, Olivier C, Urbes F, Auriault C, et al. (2002) Peptide arrays for highly sensitive and specific antibody-binding fluorescence assays. Bioconjug Chem 13: 713-720.
46. Mezzasoma L, Bacarese-Hamilton T, Di Cristina M, Rossi R, Bistoni F, et al. (2002) Antigen microarrays for serodiagnosis of infectious diseases. Clin Chem 48: 121-130.
47. Herrmann DC, Pantchev N, Globokar-Vrhovec M, Barutzki D, Wilking H, et al. (2010) Atypical Toxoplasma gondii genotypes identified in oocysts shed by cats in Germany. Int J Parasitol 40: 285-292.
48. Schares G, Globokar-Vrhovec M, Pantchev N, Herrmann DC, Conraths FJ, (2008) Occurrence of Toxoplasma gondii and Hammondia hammondi oocysts in the faeces of cats from Germany and other European countries. Vet Parasitol 152: 34-45.
49. Liesenfeld O, Kosek J, Remington JS, Suzuki Y, (1996) Association of CD4(+) T cell-dependent, interferon-gamma- mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J Exp Med 184: 597-607.
50. Cesbron-Delauw MF, (1994) Dense-granule organelles of Toxoplasma gondii: their role in the host-parasite relationship. Parasitol Today 10: 293-296.
51. Jacobs D, Vercammen M, Saman E, (1999) Evaluation of recombinant dense granule antigen 7 (GRA7) of Toxoplasma gondii for detection of immunoglobulin G antibodies and analysis of a major antigenic domain. Clin Diagn Lab Immunol 6: 24-29.
52. Lecordier L, Fourmaux MP, Mercier C, Dehecq E, Masy E, et al. (2000) Enzyme-linked immunosorbent assays using the recombinant dense granule antigens GRA6 and GRA1 of Toxoplasma gondii for detection of immunoglobulin G antibodies. Clin Diagn Lab Immunol 7: 607-611.
53. Beghetto E, Spadoni A, Buffolano W, Del Pezzo M, Minenkova O, et al. (2003) Molecular dissection of the human B-cell response against Toxoplasma gondii infection by lambda display of cDNA libraries. Int J Parasitol 33: 163-173.
54. Redlich A, Müller WA, (1998) Serodiagnosis of acute toxoplasmosis using a recombinant form of the dense granule antigen GRA6 in an enzyme-linked immunosorbent assay. Parasitol Res 84: 700-706.
55. Hiszczynska-Sawicka E, Brillowska-Dabrowska A, Dabrowski S, Pietkiewicz H, Myjak P, et al. (2003) High yield expression and single-step purification of Toxoplasma gondii SAG1, GRA1, and GRA7 antigens in Escherichia coli. Protein Expr Purif 27: 150-157.
56. Golkar M, Azadmanesh K, Khoshkholgh-Sima B, Babie J, Mercier C, et al. (2008) Serodiagnosis of recently acquired Toxoplasma gondii infection in pregnant women using enzyme-linked immunosorbent assays with a recombinant dense granule GRA6 protein. Diagn Microbiol Infect Dis 61: 31-9.